Wenxiang Zhang

机构：China Pharmaceutical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Chang'an University, Nanjing Drum Tower Hospital, Fujian Electric Power Survey & Design Institute, Jiangxi Agricultural University · ORCID：0000-0002-1077-8014

发表论文 171 篇 · 总被引 2915 次 · h-index 30

代表论文

• Combating cancer immunotherapy resistance: a nano‐medicine perspective (2025 · 癌症：英文版 · 被引 13)
• DNA tetrahedral nanoparticles: Co-delivery of siOTUD6B/DOX against triple-negative breast cancer (2024 · Journal of Controlled Release · 被引 13)
• Photosensitive Biomimetic Nanomedicine‐Mediated Recombination of Adipose Microenvironments for Antiobesity Therapy (2025 · Advanced Materials · 被引 8)
• Dissecting the tumor microenvironment in primary breast angiosarcoma: insights from single-cell RNA sequencing (2025 · Breast Cancer Research · 被引 4)
• Efficacy and safety of anti-CD38 monoclonal antibodies in patients with newly diagnosed multiple myeloma: an updated systematic review and meta-analysis based on randomized controlled trials (2025 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 3)
• Bioinformatics analysis and validation of novel biomarkers and competitive endogenous RNA networks involved in pyroptosis in diabetic nephropathy (2025 · Scientific Reports · 被引 3)